Cathrx is an innovative Australian medical device company engaged in the development of minimally invasive diagnostic and therapeutic electrophysiology catheters, used in the treatment of debilitating, and potentially lethal, cardiac arrhythmias. On the back of our extensive and continually growing patent portfolio, we have developed the world's first range of reposable diagnostic and ablation catheters. The introduction of truly reusable catheter technology will improve the care afforded patients by making prohibitively expensive procedures more accessible, and significantly reduce the environmental footprint of electrophysiology procedures. We believe that our technology platform removes many of the technical limitations associated with conventional single use catheters. With this, we envisage the development of new and exciting next generation technologies to advance the treatment of cardiac arrhythmias.
| Website | http://www.cathrx.com |
| Revenue | $5.5 million |
| Employees | View employees |
| Address | 2 8 South St Unit 8, Rydalmere, New South Wales 2116, AU |
| Phone | +61 2 9397 5700 |
| Industry | Manufacturing General, Manufacturing |
| Web Rank | 31 Million |
| Competitors | Siemens Healthineers, Johnson & Johnson, Medtronic, Abbott, Philips, Cardinal Health, Boston Scientific, Cook Medical, Terumo, Hexacath +37 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular CathRx Ltd employee's phone or email?
The CathRx Ltd annual revenue was $5.5 million in 2026.
CathRx Ltd is based in Rydalmere, New South Wales.
The NAICS codes for CathRx Ltd are [33, 339].
The SIC codes for CathRx Ltd are [38, 384].